Article Text

Download PDFPDF
CASE REPORT
Multiorgan failure associated with severe ovarian hyperstimulation syndrome due to inadequate protocol optimisation: a rare but avoidable complication
  1. Lorraine Sheena Kasaven1,
  2. Anastasia Goumenou2,
  3. Kenneth Adegoke3
  1. 1Department of Obstetrics and Gynaecology, East Kent Hospitals University NHS Foundation Trust, Margate, UK
  2. 2Department of Obstetrics and Gynaecology, Queen Elizabeth the Queen Mother Hospital, Margate, UK
  3. 3Department of Anaesthetics, Queen Elizabeth the Queen Mother Hospital, Margate, UK
  1. Correspondence to Dr Lorraine Sheena Kasaven, lk226{at}doctors.org.uk, lskasaven{at}hotmail.com

Summary

Ovarian hyperstimulation syndrome (OHSS) is a well-recognised iatrogenic complication following controlled ovarian stimulation (COS). Mild to moderate cases are mostly managed conservatively. Severe cases of OHSS can be potentially fatal. For this reason, UK clinics providing licensed fertility treatment are obliged to follow Human Fertilisation and Embryology Authority guidelines for reporting severe incidents. We present an unusually severe complication of OHSS resulting in significant morbidity. A nulligravida woman aged 25, with a 4-year history of subfertility and multiple risk factors for the development of OHSS, underwent COS. Immediately following oocyte retrieval, the patient developed symptoms of early-onset severe OHSS. The subsequent clinical deterioration of the patient precipitated multiple organ failure, including renal and hepatic dysfunction. Despite supportive management in an intensive care unit, the patient required transfer to a tertiary liver centre for specialist treatment. OHSS is a preventable complication; therefore, such an uncommon presentation of the syndrome provides important clinical lessons to be discussed.

  • obstetrics, gynaecology and fertility
  • reproductive medicine

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors LSK contributed to the writing of the case report and management of the patient. AG and KA contributed to the discussion of the case report and management of the patient.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.